16 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Antiarrhythmic Medications ... Classification - Summary ... Table Class I agents ... in this class are ... #Table #pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology ... hematology #warfarin #dosing
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Fibrillation RVR - Medications ... strongly consider using ... with digoxin, are ... #management #treatment ... #comparison #table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
include alpha blockers ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... Proposed COVID-19 Treatments ... #Pharmacology ... #Dosing #Table ... Coronavirus #SARSCOV2 #Medications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... both of these medications ... HeartFailure #HFrEF #Pharmacology ... #StageC #Cardiology
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Summary of actions ... Produces miosis during ... neuromuscular blockers ... Cholinergic #Agonists #Pharmacology ... #Table #Summary
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Summary of meta-analysis ... with ‘treatment ... in Tables 5.2 and ... EBM #Management #Pharmacology ... Personality #Disorder #Medications
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
used in the treatment ... Adherence to daily medications ... which requires dosing ... able to administer ... Antipsychotics #Pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... the use of this medication ... #Pharmacology #